n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, December 15th, 2017

The QualityStocks
Daily Stock List

graphic
graphic

GH Capital, Inc. (GHHC)

Penny Picks, OTC Markets, Barchart, Stockopedia, MarketWatch, Morningstar, and InvestorsHub reported on GH Capital, Inc. (GHHC), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Founded in 2014, GH Capital, Inc. has developed an online payment gateway (ClickDirectPay) to process online wire transfer transactions for varied online merchants, chiefly in Europe. GH Capital is a FinTech holding company and offers a going public process advisory. OTCQB-listed, GH Capital has its corporate headquarters in Miami, Florida.

The Company’s ClickDirectPay.com is its Financial Technology (FinTech) product. FinTech is an industry consisting of companies that use new technology and innovation with available resources. This is to compete in the market of traditional financial institutions and intermediaries in the delivery of financial services.

Customers utilizing ClickDirectPay can do a bank transfer fast, easily, as well as securely with their personal online banking information. Upon using ClickDirectPay, the merchant receives a real time transaction confirmation concerning the successful bank transfer.

Regarding GH Capital’s Capital Market Advisory Service, the Company guides and assists global companies from the U.S, Canada, Europe, and Asia to complete the whole going public process from the beginning. GH Capital’s corporate mission is to help small and emerging growth companies to get through the complete IPO (Initial Public Offering) procees without difficulties.

Recently, GH Capital announced that its online payment service subsidiary, ClickDirectPay (CDP) has been exploring the concept of using blockchain capabilities as part of its core offering. This will provide a financial platform, which is universally accessible, regardless of nation or currency.

Earlier this month, GH Capital announced that its online payment service subsidiary, CDP, will be beta launching its Bitcoin and alternative coin payment processing service as early as January 2018. CDP's new Bitcoin support will be launched slowly to select merchants already active with CDP services. Other companies can apply to join a closed beta test.

Mr. Wolfgang Ruecker, GH Capital’s Chief Executive Officer, said, "Allowing merchants to accept Bitcoin and other cryptocurrencies as a method of payment offers tremendous savings - especially to those with an international customer base. It is the next step in our goal to open up new markets."

GH Capital, Inc. (GHHC), closed Friday's trading session at $1.05, down 19.23%, on 189,996 volume with 333 trades. The average volume for the last 60 days is 10,156 and the stock's 52-week low/high is $0.10/$1.87.

Salon Media Group, Inc. (SLNM)

Real Pennies reported previously on Salon Media Group, Inc. (SLNM), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Founded in 1995, Salon Media Group, Inc. operates the ground-breaking, award-winning news site, Salon.com. The website has been a leader in online media since the beginning of the digital age. An Internet media enterprise, Salon has bureaus in San Francisco, California and New York, New York. The Company’s shares trade on the OTC Markets’ OTCQB.

Access to Salon Media Group’s content is free because of advertising-based revenue. The Company’s dedicated Advertising Sales team connects brand partners with Salon’s engaged, passionate audience by way of branded content, custom executions, and social outreach.

The Company produces a content Website with diverse subject-specific sections. Salon.com covers breaking news, politics, race, religion, arts and culture, entertainment, sustainability, innovation, technology, and business. It does so via investigative reporting, bold commentary and criticism, and provocative personal essays. In addition, the Company hosts compelling content, including video, slideshows, and images.

Salon is refining and expanding its original video product on the Salon.com website. It has been refining its strategy in producing original video content, to emphasize video displayed on its Website instead of on social media platforms that have barriers to monetization. Salon’s aim continues to be to add high-quality, diversified content to Salon.com to attract premium video advertising.

This past September, Salon Media Group announced that it redesigned its website Salon.com with new features and technology. The design of these is to enhance its user and commercial experiences across all digital platforms. The redesigned site offers users, particularly its fast growing mobile audience, an enhanced multi-channel experience.

Recently, Salon Media Group announced its results for the six months ended September 30, 2017. Revenue for the quarter ended September 30, 2017 was $1.2 million. This represents an increase of 20 percent from $1.0 million for the quarter ended September 30, 2016.

Revenue for the six months ended September 30, 2017 was $2.6 million. This represents an increase of 13 percent from $2.3 million for the six months ended September 30, 2016.

Net losses for the quarter ended September 30, 2017 decreased to $0.8 million versus $0.9 million for the quarter ended September 30, 2016. Net losses for the six months ended September 30, 2017 decreased to $1.4 million versus $1.7 million for the six months ended September 30, 2016.

Salon Media Group, Inc. (SLNM), closed Friday's trading session at $0.1028, even for the day, on 10 volume with 2 trades. The average volume for the last 60 days is 1,291 and the stock's 52-week low/high is $0.0541/$0.35.

Bullfrog Gold Corp. (BFGC)

PennyStockLocks, StockBomb, StockLockandLoad, Wall Street Mover, PennyStocks24, TopPennyStockMovers, InvestorTrendz, Pumps and Dumps, HEROSTOCKS, and Liquid Pennies reported previously on Bullfrog Gold Corp. (BFGC), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Bullfrog Gold Corp. is a mineral exploration company listed on the OTC Markets’ OTCQB. The Company has a strong asset portfolio with large prospective gold exploration projects located in productive mining districts within the south-western United States. Bullfrog Gold principally explores for gold, silver, and other metals. Bullfrog Gold has its head office in Grand Junction, Colorado.

The Company has its Bullfrog Project. The Bullfrog Project is approximately three miles northwest of the town of Beatty and 116 miles northwest of Las Vegas, Nevada. The Bullfrog Gold Project is in the prolific Walker Trend. Barrick Gold Corp. produced 2.1 million ounces of gold during the 1990’s from the main Bullfrog open pit, the northern one third of which is presently controlled by Bullfrog Gold.

In addition, Bullfrog Gold's lands include the entire Montgomery-Shoshone (M-S) deposit, from which Barrick produced an additional 220,000 ounces of gold. Additionally, the M-S area produced 70,000 ounces averaging 0.47 gold ounce per ton from underground mining operations in the early 1900's.

Bullfrog Gold executed an option in October 2014 to purchase 12 strategic patented claims situated contiguous to its lands and that include the north-east half of the M-S open pit mine. In March of 2015, the Company exercised a lease/option to purchase 6 patented claims, 20 unpatented claims, and 8 mill site claims from Barrick Bullfrog, Inc.

The M-S and Bullfrog deposits are amenable to heap leaching. They can support a mine cut-off grade of 0.2 g/t for leaching at coarse ROM sizes. Bullfrog Gold announced in June 2017 a base case, maiden resource estimate of 525,000 ounces of gold averaging 1.02 g/t on its Bullfrog Gold Project.

Bullfrog Gold announced in July 2017 the leasing of an additional 24 patented mining claims and the staking of 62 new mining claims at its Bullfrog Gold Project. The new lands may permit more expansions to the Montgomery-Shoshone (M-S) and Bullfrog open pit mines, have a number of worthy exploration targets, and provide more sites for heap leach pads and other project facilities.

This past August, Bullfrog Gold announced that Tetra Tech, Inc.'s NI 43-101 resource report on the Bullfrog Gold Project was posted on the website www.bullfroggold.com. The results of the report were released on June 27, 2017.

The results included measured and indicated (M&I) resource estimates of 525,000 ounces averaging 1.02 g/t using a gold price of $1200/oz and a base case cutoff grade of 0.36 g/t. Inferred resources were estimated at 120,000 ounces of gold averaging 1.20 g/t. The estimates are supported by a database, which includes 1,262 holes containing 155 miles of coring and drilling.

Bullfrog Gold Corp. (BFGC), closed Friday's trading session at $0.0916, up 13.09%, on 91,295 volume with 16 trades. The average volume for the last 60 days is 182,667 and the stock's 52-week low/high is $0.05/$0.18.

NEXT Group Holdings, Inc. (NXGH)

RedChip, BUYINS.NET, Penny Invest, StockEgg, and OTC Picks reported on NEXT Group Holdings, Inc. (NXGH), and we also report on the Company, here at the QualityStocks Daily Newsletter.

NEXT Group Holdings, Inc., through its operating subsidiaries, engages in utilizing proprietary technology and certain licensed technology to provide innovative mobile banking, mobility, and telecommunications solutions to underserved, unbanked, and emerging markets. NEXT Group Holdings owns 94 percent of the issued and outstanding shares of NEXTCALA, which is one of its four operating subsidiaries. NEXT Group Holdings is based in Miami, Florida and lists on the OTCQB

NEXT Group Holdings maintains a technology portfolio encompassing several verticals. The Companies subsidiaries are NEXT|CALA, a general purpose reloadable Visa Card; NXT|GN, a provider of a multipoint HD video platform; and NEXT|MOBILE360, a provider of mobile voice, text, and data services.

NEXT|CALA is its flagship product. NEXTCALA powers its mobile banking solution and reward program(s). The card is a safe and cost-effective substitute to carrying cash. NEXTCALA cards are acceptable wherever Visa debit cards are accepted. NEXTCALA cards can be used for all transactions.

The NXT|GN business unit, in cooperation with Cisco Systems, developed in 2012 a unique product named AVYDA powered by Telarix. This is an HD telepresence platform. It enables millions of people to connect using their mobile phones, tablets, and PCs into celebrities, talents, and healthcare and education applications on Android and iOS operating systems. AVYDA permits HD video conferences to connect point-to-multipoint.

Next Group Holdings has completed the acquisition of Tel3. Tel3 is a marketing group. With the agreement, the Company acquired the telecom marketing brand "Tel3" together with the assets and client database of Tel3.

Recently, Next Group Holdings announced it completed a significant milestone for the acquisition of international telecommunication company, Limecom, Inc. The execution of this Definitive Agreement was on September 19, 2017.

Upon completion of the acquisition, Limecom will become a wholly-owned subsidiary of NEXT Group Holdings, with projected revenues of more than $125 million for 2017, and EBITA (Earnings before Interest, Taxes and Amortization) projected at $2.5 million.

Last week, Next Group Holdings announced that on December 6, 2017, it completed its acquisition of 51 percent of SDI NEXT Distribution LLC. This was announced on August 24, 2017 as a Letter of Intent (LOI) with Fisk Holdings, LLC.

As Managing Member of the newly created LLC, Next Group Holdings will contribute $500,000, to be paid per an agreed-upon schedule over a twelve-month period commencing this month. The completed acquisition comprises an established distribution business for third-party gift cards, mobile top up, financial services and content that currently includes over 30,000 U.S. retail locations.

Additionally, NEXT Group Holdings’ 51 percent stake in SDI NEXT provides distribution for the Company's recently announced CUENTAS and MIO virtual mobile banking solutions targeted at unbanked, underbanked, and financially underserved consumers.

NEXT Group Holdings, Inc. (NXGH), closed Friday's trading session at $0.047, up 10.59%, on 455,815 volume with 21 trades. The average volume for the last 60 days is 1,080,395 and the stock's 52-week low/high is $0.0126/$0.1449.

Stealth Technologies, Inc. (STTH)

NetworkNewsWire and RedChip reported previously on Stealth Technologies, Inc. (STTH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Stealth Technologies, Inc. is a technology business listed on the OTC Markets Group’s OTCQB. The Company previously went by the name Excelsis Investments, Inc. It changed its name to Stealth Technologies, Inc. in July 2016. Stealth Technologies engages in identifying and capitalizing on technology and associated markets. The Company produces products for personal and financial protection.

Incorporated in 2010, Stealth Technologies has its corporate office in Largo, Florida. It became public through a reverse merger in 2012.

Moreover, Stealth Technologies announced in March of this year the completion of five new products. Currently, these products are staged in a large direct response retailer's quality assurance and legal department. They are under final review to ensure that marketing claims associated with each product are accurate when measured against actual performance levels of each product, and that assurance and inventory is satisfactory and has met all quality control factors. Stealth Technologies’ strategic initiative is to expand its product footprint across varied industries and distributors.

The Company has developed a group of products to protect against "electronic pickpockets," emergency response latency, credit fraud protection, and cell phone data protection. Its initial product to market is the Stealth Card.

The design of the Stealth Card is to protect the Radio-Frequency Identification (RFID) chip in a consumer's credit card from electronic stealing or pickpocketing, which uses a smartphone, credit card reader, or RFID antenna to remotely access data stored on the consumer's Smartchip. Stealth Card renders the chipped information invisible to intrusion.

The Stealth Card is a 100 percent USA product. The Stealth Card is manufactured from Stealth Technologies’ laboratory and research/development facility in West Virginia to its manufacturing facility in Massachusetts.

Development for the Stealth Card started in 2012. This is when Company Founder and Chief Executive Officer (CEO), President, and Director, Mr. Brian McFadden, observed the worldwide shift towards smart chip card technology to transmit and process credit card/debit card transactions. With Europe and Asia already making the transition away from the magnetic strip to smart chip cards, Mr. McFadden believed the United States market would need to follow suit.

To use the Stealth Card, a person places a Stealth Card in their wallet, pocket, change purse or anywhere they carry their credit cards. One card can protect up to 12 cards in a wallet. The card can be physically placed anywhere in a wallet or pocket.

The card does not need to be in the front or back of one’s wallet. The Stealth Card provides effective protection irrespective of where it’s placed in relation to one’s credit cards.

In December 2016, Stealth Technologies announced the development of the 911 Help Now Generation II Product. The 911 Help Now product provides a direct two-way voice connection to emergency service providers. The 911 Help Now pendent works by pressing the Help Now button and then a person is connected.

Stealth Technologies has a number of other products under development. The Company is exploring potential military applications of its proprietary technologies.

Along with the Stealth Card and the 911 Help Now Generation II Product, Stealth Technologies’ portfolio includes Data Secure Plus, which is new to market. Its portfolio also includes Stealth Mobile.

Stealth Technologies, Inc. (STTH), closed Friday's trading session at $0.12, down 14.89%, on 39,557 volume with 9 trades. The average volume for the last 60 days is 2,526 and the stock's 52-week low/high is $0.07/$0.7125.

Imaging3, Inc. (IGNG)

Investors Hub, MarketWatch, and OTC Markets reported on Imaging3, Inc. (IGNG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Established in 1993, Imaging3, Inc. is a provider of advanced technology medical imaging devices. It has developed a patented medical imaging technology called SmartScan™. This technology will produce 3D medical diagnostic images in real time in each of single 3D Safe-Scan, Continuous 3D Scan, as well as CT Safe-Scan mode. Imaging3 is based in Burbank, California and the Company lists on the OTCQB.

Burbank is Imaging3’s center for operations. It is also the center for the development of the Company’s proprietary and patented 3D medical imaging system, the Dominion Volumetric Imaging Scanner (DVIS).

This technology utilizes high resolution fluoroscopy to build 3D images in real time. Furthermore, the Company’s technology exposes patients to substantially less harmful radiation than contemporary imaging technologies.

Imaging3’s technology will enable healthcare professionals using Imaging3 lightweight portable devices to view 3D, high resolution images of almost any part of the human body in real time, even as they are performing procedures. 
   
The Dominion Volumetric Imaging Scanner (DVIS) is a proprietary and patented inventive mobile fluoroscopy technology. It produces high quality 3D images in Continuous 3D Scan mode, Single 3D SafeScan mode, and high quality 2D images in Continuous 2D Scan mode. DVIS is the only product in existence that can produce a combination of 2D, 3D, and CT imagery in a single device. 

Moreover, the Company’s products include 3D Printers, C-Arms. Mini C-Arms and Rentals. Imaging3 offers new, used, as well as demo C-Arms in all price ranges. In addition, it offers its C-Arm rental programs. 

Imaging3 plans to complete and submit a 510K application to the Food and Drug Administration (FDA) for its innovative 3D scanning device. On June 5, 2017, the Company hired Med-Device Consulting, Inc. to facilitate the 510(k) application to the FDA to obtain approval for its Dominion VI imaging device with patented SmartScan™ 3D technology.

Also, Imaging3 hired Intertek, Inc. on June 14, 2017 to remediate the hazard analytics and manage the FDA guidance protocols of submission requirements outlined by the FDA, to obtain approval for Imaging3’s Dominion VI imaging device.

Recently, Imaging3 announced that it received three separate quotations from insurance carriers for Directors and Officers liability insurance coverage. This sets the stage for the Company to bring on a Chief Executive Officer and other first-rate personnel to fill key Executive and Board of Directors positions.

Dane Medley, President of Imaging3, stated: “This is a necessary step as we gear up for success, and it continues the momentum towards our goal of becoming an exchange listed company offering a disruptive imaging technology to a technologically stagnant health-imaging market.”

Imaging3, Inc. (IGNG), closed Friday's trading session at $0.01, up 11.11%, on 12,102 volume with 30 trades. The average volume for the last 60 days is 155,607 and the stock's 52-week low/high is $0.0062/$0.055.

Aequus Pharmaceuticals, Inc. (AQSZF)

StockDailyReview, PennyStockTweets, Investopedia, 4-Traders, OTC Markets, Barchart, Marketwired, InvestorsHub, Stockhouse, and MarketWatch reported on Aequus Pharmaceuticals, Inc. (AQSZF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A specialty pharmaceutical company, Aequus Pharmaceuticals, Inc.’s focus is on developing, advancing, and promoting differentiated products. The Company’s development stage pipeline includes a number of products in neurology and psychiatry with the aim of addressing the need for improved medication adherence via enhanced delivery systems. OTCQB-listed, Aequus Pharmaceuticals is headquartered in Vancouver, British Columbia.

The Company’s most recent addition to the development pipeline was a long-acting form of medical cannabis. Aequus’ intention is to commercialize its internal programs in Canada together with its present portfolio of marketed established medicines.

Aequus Pharmaceuticals will look to form strategic partnerships, which would maximize the reach of its product candidates globally. Its plan is to build on its Canadian commercial platform via the launch of more products that are either created internally or brought in via an acquisition or license.

Aequus has two preclinical programs now in formulation optimization, AQS-1302 and AQS-1303. AQS-1302 is being advanced for the potential treatment of epilepsy with a once-weekly transdermal application. This is to provide patients with steady-state delivery of their medication. The expectation is that this product will decrease their risk of experiencing breakthrough seizures.

AQS-1303 is in development for the management of Nausea and Vomiting of Pregnancy (NVP). The expectation is that it will provide consistent anti-emetic control. This is while eliminating the risk of missed doses because of emesis (vomiting).

Aequus’ partners include Supernus Pharmaceuticals, Inc., Corium International, Inc., and Transdermal Research Pharm Lab. The Company will continue to expand its commercial pipeline with high quality, differentiated products. These include patented products, branded generics, and reformulated novel-delivery products within focused therapeutic areas. Aequus is developing numerous products in neurology and psychiatry. The aim is addressing the need for improved medication adherence by way of enhanced delivery systems.

This past September, Aequus Pharmaceuticals announced positive results from an initial Proof of Concept clinical study for its long-acting transdermal anti-nausea patch, AQS1303, containing the combination of pyridoxine hydrochloride and doxylamine succinate (the active ingredients in Diclegis®/Diclectin®).

The single-dose cross-over comparative bioavailability study in comparison to the presently approved oral version, Diclegis®/Diclectin®, was successfully completed in nine healthy female volunteers. The results suggested that sustained delivery of therapeutic levels of the active ingredients via the skin over a multi-day period is possible with the present formulation. The formulation was well tolerated. No serious adverse events were reported.

Last month, Aequus Pharmaceuticals announced that the European Patent Office issued an intention to grant a European patent for AQS1301, Aequus' once-weekly transdermal patch containing aripiprazole. AQS1301 is in development for the treatment of certain psychiatric disorders.

The intention of AQS1301 is to provide patients with a long-acting dosing alternative, which is comfortable, convenient, and user-friendly in an effort to promote medication adherence. This is the eighth regional patent issued or granted for AQS1301, following the U.S., Russia, Mexico, Japan, China, Canada, and Australia.

Moreover, Aequus Pharmaceuticals continues to increase revenues from its Canadian commercial arm via the on-going promotion of Vistitan™ and Tacrolimus IR. Vistitan™ (bimatoprost 0.03%) is a treatment for the lessening of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension.

Tacrolimus IR is the first to market, and currently the only available generic version of tacrolimus immediate release in Canada. This is a product used for the treatment and prevention of acute rejection following organ transplantation.

Aequus Pharmaceuticals, Inc. (AQSZF), closed Friday's trading session at $0.1806, up 5.00%, on 58,550 volume with 13 trades. The average volume for the last 60 days is 27,612 and the stock's 52-week low/high is $0.115/$0.3491.

graphic

The QualityStocks
Company Corner

graphic
graphic

MGX Minerals Inc. (MGXMF)

The QualityStocks Daily Newsletter would like to spotlight MGX Minerals Inc. (MGXMF). Today, MGX Minerals Inc. closed trading at $0.84924, up 0.97%, on 282,189 volume with 96 trades. The stock’s average daily volume over the past 60 days is 140,927 and its 52-week low/high is $0.2864/$2.119.

MGX Minerals Inc. (CSE:XMG) (OTCQB:MGXMF) (FKT:1MG) is pleased to report that the initial ground survey is nearing completion in preparation for a detailed 3D seismic survey of its Utah Petrolithium project. The survey of the Project includes approximately 9,000 source points. This model will outline subsurface geological formations and structures favorable for accumulations of oil and gas as well as lithium brine bearing formations.

MGX Minerals Inc. (CSE: XMG) (FKT: 1MG) (OTCQB: MGXMF) is a diversified Canadian resource company developing large-scale mineral portfolios in specific commodities and jurisdictions in North America. The company controls significant interest in lithium, magnesium and silicon assets that offer streamlined development timelines and low capital expenditures. MGX Minerals and its engineering partner have developed a patent-pending, low-energy design process to extract valuable minerals from the abundant, highly mineralized brine wastewater produced each year by oil and gas companies.

This proprietary, petrolithium process rapidly concentrates lithium and other minerals from brine in less than a day. That's a stunning advancement from the conventional method of extracting minerals from brine through an evaporation process that can take up to 18 months, requires hundreds of acres of land, and averages less than a 50 percent mineral recovery rate. Using this advanced water purification technology, MGX Minerals cleans the wastewater that accompanies petroleum as it's being pulled up to the surface. The company's petrolithium process eliminates the need to inject contaminated wastewater back into the ground, which prevents drinking water contamination and possible earthquakes.

In January 2017, MGX Minerals successfully recovered concentrated lithium from heavy oil evaporator blowdown wastewater using its rapid recovery process, an accomplishment independently confirmed by the Saskatchewan Research Council. In August 2017, the company also successfully processed wastewater and lithium brine from eight North American projects at its one-cubic-meter-per-hour processing plant, proving the technology is economically viable. Research group Global Water Intelligence expects the wastewater treatment industry to grow into a $45 billion market annually by 2025, which suggests there are ample revenue-generating opportunities for MGX Minerals technology.

Lithium, the "white gold" of the new energy economy, is the key to clean energy development as global demand for hybrid and electric vehicles, high-drain portable electronic devices, and large-scale energy storage systems ramps up. Grand View Research, Inc. reports that the global lithium-ion battery market is expected to reach $93.1 billion by 2025. Current market forces show a high demand for lithium and a low supply, which further supports the necessity of MGX Mineral's cleaner, faster method of extracting high-value minerals from brine wastewater.

MGX Minerals is led by a team of industry standout performers who have worked in the mining and technology industries for decades. The leadership team is joined by an array of top-notch technical partners with unmatched experience in the oil and gas sectors, environmental services industry, marketing and product development, along with applied research and commercial development of technologies. Disclaimer

MGX Minerals Inc. Blog

MGX Minerals Inc. News:

MGX Minerals Advances 110,000 Acre Petrolithium Project Paradox Basin, Utah

MGX Minerals to Acquire Zinc Air Battery Developer ZincNyx Energy Solutions

MGX Minerals Closes $6.3 Million First Tranche of Non-Brokered Private Placement

ORHub, Inc. (ORHB)

The QualityStocks Daily Newsletter would like to spotlight ORHub, Inc. (ORHB). Today, ORHub, Inc. closed trading at $0.40, up 2.56%, on 29,453 volume with 12 trades. The stock’s average daily volume over the past 60 days is 37,250 and its 52-week low/high is $0.20/$2.09.

ORHub, Inc. (ORHB) is a cloud-based software platform designed to transform the business of surgery into a value-based model. The platform empowers care providers at every stage of the surgical process to collaborate, organize, deliver, measure, and reimburse in one intuitive, easy-to-use program. This significantly decreases cost and improves outcomes by eliminating inefficiencies, duplications of effort, and errors and omissions that result from siloed processes in outdated software and poor handoffs from one part of the care process to another.

The need for ORHub is clear. Health care costs are out of control at more than 17% of US GDP, which equates to over $3 trillion per year. With costs rising every year due to an aging population and increasingly expensive treatments, providers are under severe pressure to become more efficient and reduce costs. This is happening because payors are aggressively reducing reimbursements and finally moving away from fee-for-service and toward a performance-based reimbursement system referred to as value-based health care.

Accurately measuring the cost of treating a condition and relating that cost to the patient's outcome is at the heart of value-based health care. Institutions that have adopted this model have reaped savings of 20-40% on their overall cost of care. Unfortunately, today's siloed IT systems are fundamentally at odds with this process. Legacy health care solutions come from a fee-for-service world and have reinforced the problem and produced a system with erratic quality and unsustainable costs. Most health care applications today are incremental improvements on these existing systems or are simple digital implementations of antiquated pen-and-paper processes.

Providers wanting to practice value-based health care need value-based software. ORHub creates a value-based solution that will revolutionize surgical care delivery by tracking the cost of treating a condition from diagnosis to discharge, and tracking outcomes that resulted from that treatment.

In an industry where major IT rollouts traditionally cost millions of dollars and take an average of eighteen months, pilot installations of ORHub have been completed in less than a month. By avoiding integration with legacy systems completely through a radically comprehensive and collaborative approach, providers see results right away. This approach produces real-time metrics in a uniform manner at any institution, which makes it ideal for large providers looking to make improvements across the board at multiple facilities.

ORHub started as a pilot program developed in cooperation with a major Southern California hospital. It has since expanded operations into a second facility at the number two non-profit hospital system in the US. Three additional pilot programs are scheduled prior to a national launch. The company has raised more than $1.6 million as of January 2017.

The company is also a showcase member of the startup program at Microsoft, which has been a key partner by providing financial assistance, strategy, introductions to influencers and mentors, and access to its sales organization who see ORHub as an exciting partner to expand the utilization of Microsoft Surface devices and Azure Cloud. Microsoft is funding a major case study in partnership with Intel about the impact of ORHub on participating institutions to be concluded sometime in Q2 2017.

ORHub's leadership team is helmed by Colt Melby, who was appointed CEO in 2016 and has been crucial to developing and executing the company's business strategy. Mr. Melby's extensive business experience includes the NASDAQ uplisting of Smith and Wesson (now American Outdoor Brands), CUI Global Inc., and Quest Resource Holdings Corp. His wealth of information and relationships have been vital in helping the company go from concept to production in institutional medicine in less than a year.

Delivering surgical care to a single patient is a complex process that may take half a dozen companies and more than a dozen departments cooperating inside and outside the care facility. ORHub simplifies and streamlines this process by enabling vendors, providers, and surgeons to collaborate on providing care. Disclaimer

ORHub, Inc. Blog

ORHub, Inc. News:

ORHub, Inc. (ORHB) Provides 2017 Business Highlights and Sets Special Warrant Exercise Price

ORHub, Inc. (ORHB) Signs 5-year Revenue Agreement with Nationally Recognized "Top 100" Hospital

ORHub, Inc. (ORHB) Warrants Set to Expire on December 31, 2017

RJD Green Inc. (RJDG)

The QualityStocks Daily Newsletter would like to spotlight RJD Green Inc. (RJDG). Today, RJD Green Inc. closed trading at $0.01, up 13.64%, on 1,493,700 volume with 29 trades. The stock’s average daily volume over the past 60 days is 2,097,381, and its 52-week low/high is $0.0037/$0.029.

RJD Green Inc. (RJDG) is a holding company with a focus on acquiring and managing assets and companies in three divisions. These initial high-growth enterprise opportunities offer diversity in separate recession resistant markets. The division holdings include:

  • RJD Green Healthcare Services – provides services to reduce cost and enhance management and operational capabilities in the healthcare sector.
  • Earthlinc Environmental Services – provides green environmental services and technologies.
  • Silex Holdings – acquires specialty construction and industrial manufacturing assets.

RJD Green Healthcare Services, through its wholly owned subsidiary IOSOFT Inc., provides proprietary software and IT support for medical billing, healthcare claims adjudication, and electronic payments between healthcare payers and providers. IOSOFT's unique payment technologies and services or software can be integrated with existing systems of healthcare payers such as Blue Cross, Aetna, CIGNA and others. IOSOFT provides targeted offerings for healthcare providers, provider networks, physicians and hospitals, and clearinghouse companies.

Earthlinc Environmental Solutions was formed to bring forward green-applied technologies and offer environmental services with a focus on North America. The division's first acquisition, Animal Waste Management, is launching operations of a patented, fully developed technology for processing waste produced on commercial poultry and hog farms. Development of this technology was supported by the University of Arkansas and the Missouri Department of Natural Resources. This important technology improves the farm's productivity and is competitively priced with the current expense of handling waste removal at these sites.

The company's third division – Silex Holdings Inc. – was formed to acquire and manage high-growth assets and business enterprises in the industrial and construction specialty services sectors. With its first acquisition of Silex Interiors, a manufacturer, distributor and installer of counter tops, cabinets and related kitchen and bath products, the division is poised to expand into major national markets through internal expansion, acquisition and franchising. The company is modeled to operate a minimum of four corporately owned locations with 12 to 18 franchise locations nationwide.

RJD Green seeks to participate as owners, partners or in joint ventures in a wide range of business enterprises. The company's goal of creating a successful, enjoyable business enterprise for its company team and staff, along with its business partners and investors, is paired with the goal of maximizing the business potential of the enterprise by enhancing profits and the quality of the company. Disclaimer

RJD Green Inc. Company Blog

RJD Green Inc. News:

RJD Green, Inc. Updates Progression of Animal Waste Management and 2017 10K Filing

RJD Green Inc. Appoints Director

RJD Green Inc. Subsidiary, IOSOFT, Discusses Contracts Procured and Revenue Expectations

Greenkraft, Inc. (GKIT)

The QualityStocks Daily Newsletter would like to spotlight Greenkraft, Inc. (GKIT). Today, Greenkraft, Inc. closed trading at $0.135, up 35.00%, on 100 volume with 1 trade. The stock’s average daily volume over the past 60 days is 7,755 and its 52-week low/high is $0.02/$0.20.

Greenkraft, Inc. (GKIT) is a nationally recognized company specializing in the production of alternative fuel automotive products, including engines and commercial trucks. Located in Santa Ana, California, the company's mission is to provide clean, green, energy efficient automotive products that have a price advantage coupled with unparalleled American performance. Established in 2008, Greenkraft, Inc. serves the commercial truck market powered by the alternative fuels CNG and LPG in classes 4, 5, 6 and 7.

Greenkraft's new line of trucks, known as the G3 and G4, will accommodate weights of 26,000 lbs. and 33,000 lbs., respectively. George Gemayel, CEO of Greenkraft, Inc., said the demand for larger trucks that run on alternative fuels continues to increase.

"Greenkraft is going to revolutionize the trucking industry with these new 26,000 and 33,000 lbs. trucks that run on CNG and PROPANE fuel," Gemayel states in a press release. "The only way we can meet increased demand for Greenkraft products is to expand our current factory. This expansion is one of many factors that will substantially increase the Company's revenue in 2017."

Greenkraft produces a cab forward design for its commercial trucks, which allows the passenger area to be much larger than in other similar sized vehicles. Several tank capacity options exist, making it easy to select the most efficient model for a client's specific needs. Greenkraft is one of the only companies in the world to offer a refrigeration option with an alternative fuel truck – an essential, must-have option for many businesses.

Greenkraft trucks, considered among the best performing in the heavy-duty market, are used in a variety of industries and in some of the nation's largest cities. The company also offers a line of trucks designed to run with a package from Allison Transmission Holdings, Inc. (NYSE: ALSN), which gives clients the option of purchasing a fully automatic transmission vehicle. This option expands the size of the driver pool since fully automatic shifting reduces driver fatigue, contributes to solving the issue of driver retention, and it is easy to use.

CNG and LPG conversion systems made by Greenkraft are available for several major automobile brands including Ford, GM and Isuzu/GM. Installation, service, parts and warranty are all available through Greenkraft facilities and its partners. Disclaimer

Greenkraft, Inc. Blog

Greenkraft, Inc. News:

Greenkraft, Inc. (GKIT) Sees Jump in Sales for its Commercial Truck Line

Greenkraft, Inc. (OTCQB: GKIT) Signs Supply Contracts for its Alternative Fuel Commercial Trucks, Rising to Meet Industry Demand

Greenkraft, Inc.'s (GKIT) Alternative Fuel Engine Awarded Certification for Exceeding California's Clean Air Act Standards

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA). Today, Marijuana Company of America Inc. closed trading at $0.03545, up 5.51%, on 7,054,656 volume with 384 trades. The stock’s average daily volume over the past 60 days is 8,002,255 and its 52-week low/high is $0.0181/$0.114.

Marijuana Company of America Inc. (MCOA) (the "Company") are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA's CEO, founded the first marijuana company ever to trade on a US stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing expotentially and consequently the founders of MCOA have contructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can also be used to produce products that are carbon neutral or even carbon negative, like the longest, strongest natural fiber on earth, building materials that are mold, pest and fire proof, super foods and so much more for additional business opportunities. No part of the plant is left unused and the Company's overall stategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented exponential growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015's $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal and cannabis and industrial hemp sectors. The Company's business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA's strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product "hempSMART Brain," is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience. Disclaimer

Marijuana Company of America Inc. Blog

Marijuana Company of America Inc. News:

Marijuana Company of America Launches New hempSMART™ Pain Product

Marijuana Company of America Partners With HoneyB Healthy Living to Launch the BeniHemp Brand

Marijuana Company of America Provides Update on 30,000 Sq. Ft. Cultivation Facility in Washington State

Skinvisible, Inc. (SKVI)

The QualityStocks Daily Newsletter would like to spotlight Skinvisible, Inc. (SKVI). Today, Skinvisible, Inc. closed trading at $0.0425, off by 11.46%, on 851,332 volume with 50 trades. The stock’s average daily volume over the past 60 days is 208,165 and its 52-week low/high is $0.003/$0.33.

Skinvisible, Inc. (SKVI) through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc., is a Research and Development company whose patented Invisicare® technology can be used to revitalize or create new medical or skincare products, allowing a company that licenses Skinvisible's formulations to sell their own patented product and combat generic competitors.

A prescription dermatology product can generate $100 million or more a year, with the potential to lose 50-90% of that revenue when it goes off patent. Preserving that revenue is why the licensing of a product made with Invisicare is a very desirable option for many companies. The Company has developed a pipeline of 40 products using Invisicare, with a primary focus on optimizing the performance and increasing the value of "gold standard" dermatology drugs and licensing them to international and multi-national companies in the pharmaceutical, over-the-counter and cosmeceutical markets.

Invisicare® is a high performance topical and transdermal delivery system which enhances the delivery of drugs and other ingredients to and through the skin. The key to Skinvisible's patented technology and trademarked Invisicare® family of polymer delivery vehicles is its formula and process for combining hydrophilic and hydrophobic polymers into stable complexes in water emulsions. Invisicare® can be a key component of life cycle management, extending the life with a new patent-protected product, dramatically expanding the company's revenue stream.

Independent studies of Invisicare ® have shown the following benefits:

  • Active ingredients stay on the skin for up to four hours or more and resist wash off and rub off.
  • Delivery method results in improved efficacy, reduced skin irritation and lower required dosage.
  • Unique formulations are non-drying and provide the ability to control the release of active ingredients.
  • Products form a protective barrier, which means normal skin respiration and perspiration occur and the product wears off as part of the skin's natural exfoliation process.

Terry Howlett, President, founder and CEO of Skinvisible Inc., said the Company has more than 15 years of scientific research and product development experience. All development is conducted using stringent pharmaceutical standards. The Company has licensed a number of its formulations including a prescription hemorrhoid cream in the USA, its anti-aging Kintari® line of products and DermSafe®, its non-alcohol hand sanitizer to a licensee in China. Producing licensed products for the booming cannabis industry is also an important element of the company's business strategy.

Skinvisible's foray into the rapidly expanding market for medicinal and recreational cannabis products is already underway with the development of the company's first hemp-derived CBD (cannabidiol) products. Skinvisible has negotiated an exclusive licensing deal in Canada with Canopy Growth Corporation, one of the world's leading cannabis companies. As part of the company's overall growth strategy, Skinvisible is also negotiating with a Licensed Producer in Las Vegas where Skinvisible scientists will develop THC (tetrahydrocannabinol) products for the legal recreational and medical marijuana market for the USA. Notably, Skinvisible is actively pursuing potential licensees through-out the world where medical cannabis is legal. These licensees will have the exclusive right to manufacture and distribute Skinvisible's cannabis products within their territory.

"We are excited about the results we are already seeing just with our hemp-derived CBD products," Howlett says. "Our science shows that our CBD products release almost four times that of market leaders and our transdermal product had an 81% penetration rate at 6 hours. These results are significant and provide the difference between ordinary cannabis products and ones enhanced by Invisicare."

The Company's business model includes out-licensing its formulations for a development fee, license fee and on-going royalties in addition to selling its Invisicare polymers to its licensees. Disclaimer

Skinvisible, Inc. Blog

Skinvisible, Inc. News:

Skinvisible Announces Proposed Merger with Quoin Pharmaceuticals

New Skinvisible, Inc. (SKVI) Subsidiary Signs Exclusive License Agreement to Distribute Its Topical Cannabis Products in the USA

Skinvisible, Inc. (SKVI) Engages NetworkNewsWire for Corporate Communications Solutions

Grey Cloak Tech, Inc. (GRCK)

The QualityStocks Daily Newsletter would like to spotlight Grey Cloak Tech, Inc. (GRCK). Today, Grey Cloak Tech, Inc. closed trading at $0.0028, off by 6.67%, on 7,314,879 volume with 39 trades. The stock’s average daily volume over the past 60 days is 9,470,312 and its 52-week low/high is $0.0027/$0.1499.

Grey Cloak Tech, Inc. (OTCQB: GRCK), a Las Vegas, Nevada-based company, aims to expand into the rapidly growing cannabinoid (CBD) market through the pending acquisition of Eqova Life Sciences, which focuses on providing a full spectrum line of clinical-grade hemp oil (CBD) products to the medical practitioner market. Eqova Life Sciences, based in Denver, Colorado, develops its own high quality, branded product line of hemp oil health products, with the offer of producing private labels to qualified partners.

Eqova Life Sciences recently exhibited the company's CBD products at the Integrative Medicine Summit in Denver, Colorado, which was attended by over 200 medical professionals. As part of the exhibition, Eqova Life Sciences also debuted its new CannaBio Salve, an innovative topical salve infused with several aromatic natural oils. The company's formulations combine the scientifically-validated, powerful benefits of cannabinoids in standardized products which are then distributed to patients under the care of qualified health practitioners. All Eqova products are carefully researched and go through rigorous third-party testing before and after marketing, providing the security of a clinical-grade product made in cGMP Compliant Labs located in the United States.

According to The Hemp Business Journal, the CBD products marketplace is projected to grow 700 percent by 2020 with annual sales reaching $2.1 billion. The purchase of Eqova Life Sciences would be a natural fit for the company, which has been looking for a way to build shareholder value by adding acquisitions from the rapidly growing CBD sector. Grey Cloak Tech believes medical practitioners seeking high-quality CBD products represent a vastly underserved market. To date, no other hemp oil company has exclusively focused on providing clinical-grade, full-spectrum hemp oil products to this important segment of the medical community.

Grey Cloak Tech also develops advanced software to overcome costly digital threats, most commonly known as online fraud. Grey Cloak Tech leads the industry with continuous development of the most comprehensive and effective weapons against online security threats. The company's proprietary digital advertising fraud detection software, Fraudlytic, provides a cloud-based, secure platform that monitors Internet traffic in real time, blocking malicious and false clicks, while allowing real consumers to view offers and make purchases. Disclaimer

Grey Cloak Tech, Inc. Blog

Grey Cloak Tech, Inc. News:

Grey Cloak Tech Announces Hiring of Stephen Goldberg as New Chief Marketing Officer for CBD.co

Grey Cloak Tech, Inc. Announces Purchase of CBD.co Domain and Plans to Build a CBD Marketplace

Grey Cloak Tech, Inc. to Introduce CannaBio Salve at MJBizCon in Las Vegas

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

PennyStockProphet
(LFIN) +308.41%

2.

MarketClub Analysis
(PIXY) +76.53%

3.

QualityStocks
(GKIT) +35.00%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251